Antiplatelet in Cerebrovascular Accident(CVA)  

Authors: Lal Shahbaz, Shua Nasir , Alvia Saad, Muhammad Saad Usmani

1 Zia-Uddin Hospital, Karachi
2 Zia-Uddin Hospital, Karachi
3 Zia-Uddin Hospital, Karachi, Karachi.
4 Liaquat College of Medicine & Dentistry & Darul Sehat Hospital, Karachi

Volume 22 | Issue 1

Published: October 22, 2026

Abstract

To determine the efficacy and safety of Aspirin alone and of combined Aspirin and Clopidogrel in treatment of acute Ischemic CVA. Method: A hospital based randomized controlled trial conducted at Abbasi Shaheed Hospital, Karachi from March 2013 to August 2013. Patients with Ischemic stroke > 12 hours not known to have past ischemic symptoms with confirmation of ischemia on Head CT or MRI Brain were included. Patients with hemorrhage or other pathology such as vascular malformation, tumor, abscess, and patients with known hypersensitivity to aspirin or clopidogrel, patients with recurrent stroke were excluded. Result: Among 56 patients with ischemic stroke the mean age of the patients was 57.50 ± 13.68 years. There were more females n=35(62.5%) compared to males 21 (37.5%) with sex ratio of 1.6:1. The risk factors like Diabetes was found in n= 32 (57.1%), hypertension in 44 (78.6%), ischemic heart disease n=10 (17.9%), hypercholesterolemia n=33 (58.9%), obesity in n=38 (67.9%). The treatment groups receiving aspirin+ placebo in group 1 and group 2 receiving aspirin + Clopidogrel, the rate of restroke was found in only n=3 (5.3%) patients taking aspirin alone. However in group 2 receiving aspirin + Clopidogrel, patients reported gastrointestinal bleeding n=2 (3.5%) and intracerebral hemorrhage. The mortality rate was n=6 (0,7%). Conclusion: CRP levels are important predictors of myocardial damage and can be used as prognostic marker for acute coronary syndrome.

Keywords: Ischemic Stroke, Dual antiplatelet,

DOI: (All papers should be submitted electronically. All submitted manuscripts must be original work that is not under submission at another journal or under consideration for publication in another form, such as a monograph or chapter of a book. Authors of submitted papers are obligated not to submit their paper for publication elsewhere until an editorial decision is rendered on their submission. Further, authors of accepted papers are prohibited from publishing the results in other publications that appear before the paper is published in the Journal unless they receive approval for doing so from the Editor-In-Chief.)

Download Full Text PDF